CD274 and neoplasm: This is accompanied by decreased tumor cell immune escape from CTL-mediated lysis and reduces tumor growth, suggesting novel cancer immunotherapy to block PDL1 expression specifically in hypoxic tumor cells by administering NO mimetics.